Center for NanoSpace Technologies, Inc.

Technologies for the Future ....



Forward looking healthcare researchers, policymakers specialists, and the population at-large propose powerful yet inexpensive NanoMEMS technology solutions.  More self-directed screening and early diagnosis, end of managed care, dramatic cost containment with unobtrusive, noninvasive complementary miniaturized devices, pervasive internet work addressing for real-time monitoring and telemedicine at the physiological and molecular levels of observation and therapy are potential applications of nanotechnology to support major societal issues.


For example: wearable microprocessors, wireless communications, diagnostic laboratories-on-a-chip, NanoMEMS systems for in-vivo sensors and devices for cancer detection and therapeutics, patch-sized transmitters, peel-n-stick omnipresent detectors, handheld battery-operated multifunctional environmental testers, human-ingestable clinical analyzers, implantable or wearable microscopic diagnostic hardware, are only a few applications in the human projects.



Develop Miniaturized Medical Screening, Diagnostic and Therapeutic Devices



  • Wearable (Stampsize) Stethoscopes

  • Restorative Hearing Aid Patch

  • Ingestible Colon-Cancer Screening Pill

  • Implantable Neuro-Controls

  • Implantable Drug Delivery Systems

  • Limb Prosthetics

  • Assistive/Enabling/Mobility Orthotics

  • Sociological/Psychological/Habilitation Interventions

        The market segments for commercial products realized from these projects fall into three primary categories: non-implantable diagnostic devices, wearable biomedical monitors and surgical implants. Projected gross sales value is in the $Billions.  The total world market value for wearable stethoscopes is projected at $100Million annually.  An ingestible colon cancer screening pill for colon cancer screening is conservatively projected at $1Billion annually (currently 2 million humans screened per year @ $500/screen).


        These projects are best developed through partnerships and joint re-sourcing of bioengineers, product development labs, and patient clinical test sites in collaboration with medical research institutions and commercial NanoMEMS foundries.